Aurora Cannabis

At Aurora Cannabis Inc., we are at the forefront of the global cannabis industry, driven by a commitment to science, innovation, and helping people improve their lives. Through groundbreaking technology and a patient-first philosophy, we are revolutionizing how the world perceives and utilizes cannabis. Our operations span the entire cannabis value chain, from advanced genetic research and cultivation to the development and distribution of high-quality medical and adult-use cannabis products. We are pioneers in developing proprietary cultivation techniques and technologies that enhance the biosecurity of our production facilities, reduce costs, and improve product quality. A significant technological breakthrough includes the development of powdery mildew-resistant cannabis cultivars, a testament to our dedication to scientific research and innovation. This advancement not only strengthens our own production but also has the potential to benefit the broader cannabis industry.

Our innovation extends to product development, where we offer a diverse portfolio of brands catering to various market segments, including medical, wellness, and adult recreational use. We have invested heavily in state-of-the-art production facilities, such as our Aurora Nordic facility in Denmark, which utilizes high-tech cultivation methods to produce pharmaceutical-grade medical cannabis for European and international markets. Furthermore, our commitment to research and development is evident in our collaborations with academic institutions like the University of British Columbia to advance cannabis science. We are also exploring novel delivery systems, such as CBD lozenges developed in partnership with Vectura Fertin Pharma, to provide patients with a wider range of therapeutic options. By consistently pushing the boundaries of cannabis science and technology, Aurora Cannabis Inc. is not just participating in the industry; we are actively shaping its future, ensuring safe, reliable, and innovative cannabis solutions are accessible globally.